Pomarza doses as high as 50 mg as a single dose in healthy patients, and 10 mg as once-daily multiple doses in multiple myeloma patients have been studied without reported serious adverse reactions related to overdose. In available data, pomalidomide was found to be removed by haemodialysis.
In the event of overdose, supportive care is advised.